May 1 (Reuters) - Industrial tools maker Ametek Inc ( AME )

on Thursday reported a modest uptick in first-quarter

earnings, aided by robust sales and order growth at its

electromechanical business.

The Berwyn, Pennsylvania-based company expects to weather

the tariff-led macroeconomic environment with a strong demand

outlook and robust cash flow conversion.

"While uncertainty has increased as a result of the global

trade dynamics, we believe we can offset tariff headwinds

through the implementation of mitigation actions," CEO David

Zapico said.

Ametek ( AME ), which makes testing and measurement instruments,

medical devices as well as automation solutions, reiterated its

annual adjusted earnings forecast of $7.02 to $7.18 per share.

It expects full-year sales growth of low-single digits,

compared with a year ago.

The company's adjusted earnings grew 7% to $1.75 per share

in the first quarter from a year ago, beating analysts' average

estimate of $1.69, according to LSEG data.

However, its quarterly sales of $1.73 billion were slightly

lower than analysts' view.

Ametek's ( AME ) sales at the electromechanical group business

touched a record high of $588.3 million in the three months

ending March 31, led by strong order growth in the Paragon

Medical business.

Sales at its electronic instruments group business, which

caters to aerospace, medical, power and industrial markets,

slipped 1% to $1.14 billion.